<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The intracellular calcium overload resulting from <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> excitotoxicity is considered major determinant for <z:hpo ids='HP_0002529'>neuronal loss</z:hpo> during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Moreover, <z:hpo ids='HP_0001941'>acidosis</z:hpo> mediated ASIC1a activation has also shown to promote intracellular calcium overload following ischemic insult </plain></SENT>
<SENT sid="2" pm="."><plain>Interestingly, ASIC1a was found to be inhibited by <z:chebi fb="1" ids="35475">NSAIDs</z:chebi> particularly <z:chebi fb="0" ids="5130">flurbiprofen</z:chebi> and <z:chebi fb="1" ids="5855">ibuprofen</z:chebi>, which could be exploited in hypoxic conditions like <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This prompted us to investigate neuroprotective effect of <z:chebi fb="0" ids="5130">flurbiprofen</z:chebi>, besides its possible downstream signaling mechanism in <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent model</z:e> of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="0" ids="5130">flurbiprofen</z:chebi> treatment, 30 min prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and 4 h post-reperfusion, afforded significant neuroprotection from ischemic injury as evidenced by reduction in cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and neurobehavioral deficit </plain></SENT>
<SENT sid="5" pm="."><plain>Further, an early calcium dependent rise in levels of <z:chebi fb="95" ids="16301">nitrite</z:chebi> and <z:chebi fb="14" ids="32506">MDA</z:chebi> was also found to be significantly (P &lt; 0.01) reduced in ischemic brain regions following <z:chebi fb="0" ids="5130">flurbiprofen</z:chebi> pretreatment </plain></SENT>
<SENT sid="6" pm="."><plain>It also reduced the proteolytic products (SBDPs) caused by ischemic activation of calcium dependent protease calpain </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, the ex-vivo studies with <z:chebi fb="0" ids="5130">flurbiprofen</z:chebi> in rat brain synaptoneurosomes inhibited the acid mediated rise in intracellular calcium levels </plain></SENT>
<SENT sid="8" pm="."><plain>These studies thus provide neuroprotective profile of <z:chebi fb="0" ids="5130">flurbiprofen</z:chebi> in focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> with its selective effect on ASIC1a </plain></SENT>
</text></document>